Understanding Lipohypertrophy in Diabetes

Abstract

Lipohypertrophy (LH) is a significant complication of insulin therapy affecting approximately 25-41.8% of diabetes mellitus patients. This qualitative study investigates patients' and healthcare professionals' (HCPs) attitudes toward LH and insulin injection practices. Through online focus groups and interviews involving 11 patients and 10 HCPs, the research explores the prevalence and risk factors LH. Key findings reveal that modifiable risk factors, including improper injection practices like site non-rotation and needle reuse, significantly contribute to LH development. The research emphasizes the critical need for comprehensive patient education, improved HCP training, and technological advancements in insulin delivery. Recommendations include developing structured education programs, investing in advanced delivery technologies, conducting large-scale research, and creating targeted interventions for high-risk populations. This study provides crucial insights into LH management, advocating for a proactive approach to prevent complications, improve patient outcomes, and reduce healthcare system costs.